PRKRA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.877600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.172200E-01
Normal-vs-Stage2
8.278600E-01
Normal-vs-Stage3
6.529800E-01
Normal-vs-Stage4
5.074800E-01
Stage1-vs-Stage2
1.942570E-01
Stage1-vs-Stage3
9.360000E-01
Stage1-vs-Stage4
1.565030E-01
Stage2-vs-Stage3
3.363200E-01
Stage2-vs-Stage4
4.703200E-01
Stage3-vs-Stage4
2.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.986800E-01
Normal-vs-AfricanAmerican
6.351800E-01
Normal-vs-Asian
8.925200E-01
Caucasian-vs-AfricanAmerican
6.362000E-01
Caucasian-vs-Asian
8.984600E-01
AfricanAmerican-vs-Asian
7.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.919000E-01
Normal-vs-Female
8.666400E-01
Male-vs-Female
9.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.377200E-01
Normal-vs-Age(41-60Yrs)
4.866200E-01
Normal-vs-Age(61-80Yrs)
9.677800E-01
Normal-vs-Age(81-100Yrs)
6.192600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.494200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.632600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.733400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.058410E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.757300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.700800E-01
Normal-vs-Daily Drinker
7.899800E-01
Normal-vs-Weekly Drinker
8.633200E-01
Normal-vs-Occasional Drinker
5.238800E-01
Normal-vs-Social Drinker
8.978000E-01
Non Drinker-vs-Daily Drinker
9.273600E-01
Non Drinker-vs-Weekly Drinker
3.879400E-01
Non Drinker-vs-Occasional Drinker
6.019700E-02
Non Drinker-vs-Social Drinker
4.234000E-01
Daily Drinker-vs-Weekly Drinker
4.303600E-01
Daily Drinker-vs-Occasional Drinker
7.836000E-02
Daily Drinker-vs-Social Drinker
4.726800E-01
Weekly Drinker-vs-Occasional Drinker
3.869200E-01
Weekly Drinker-vs-Social Drinker
9.517400E-01
Occasional Drinker-vs-Social Drinker
3.568000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.010590E-01
Normal-vs-Grade 2
8.523400E-03
Normal-vs-Grade 3
2.303600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.496100E-03
Grade 1-vs-Grade 3
3.615500E-02
Grade 1-vs-Grade 4
1.010590E-01
Grade 2-vs-Grade 3
7.964000E-01
Grade 2-vs-Grade 4
8.523400E-03
Grade 3-vs-Grade 4
2.303600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.796600E-01
Normal-vs-NonDiabetic
8.386000E-01
Diabetic-vs-NonDiabetic
1.289220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.265600E-01
Normal-vs-NoPancreatitis
9.575800E-01
Pancreatitis-vs-NoPancreatitis
5.982400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.870600E-01
Normal-vs-N1
8.196800E-01
N0-vs-N1
4.585600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.426200E-01
Normal-vs-TP53-NonMutant
7.879600E-01
TP53-Mutant-vs-TP53-NonMutant
6.840800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
